XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Note 3 - Financial Instruments and Fair Value Measurements
9 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

3.

Financial Instruments and Fair Value Measurements

 

The Company’s financial instruments consist of money market funds. The following tables show the Company’s cash equivalents carrying value and fair value at September 30, 2025 and December 31, 2024 (in thousands):

 

  

As of September 30, 2025 (unaudited)

 
          

Quoted

  

Significant

     
          

Priced in

  

other

  

Significant

 
          

active

  

observable

  

unobservable

 
  

Carrying

  

Fair

  

markets

  

inputs

  

inputs

 
  

Amount

  

Value

  

(Level 1)

  

(Level 2)

  

(Level 3)

 

Assets

                    

Money market funds

 $2,797  $2,797  $2,797  $  $ 

Total assets

 $2,797  $2,797  $2,797  $  $ 

 

  

As of December 31, 2024

 
          

Quoted

  

Significant

     
          

Priced in

  

other

  

Significant

 
          

active

  

observable

  

unobservable

 
  

Carrying

  

Fair

  

markets

  

inputs

  

inputs

 
  

Amount

  

Value

  

(Level 1)

  

(Level 2)

  

(Level 3)

 

Assets

                    

Money market funds

 $1,819  $1,819  $1,819  $  $ 

Total assets

 $1,819  $1,819  $1,819  $  $ 

 

Cash equivalents – Cash equivalents of $2.8 million as of September 30, 2025 and $1.8 million as of December 31, 2024, consisted of money market funds. Money market funds are classified as Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets.

 

Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.

 

There have been no changes to the valuation methodologies utilized by the Company during the nine months ended September 30, 2025 compared to the year ended December 31, 2024. The Company evaluates transfers between levels at the end of each reporting period. There were no transfers of financial instruments between levels during the nine months ended September 30, 2025 and the year ended December 31, 2024.